| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.44B | 1.68B | 1.89B | 2.11B | 2.18B | 1.86B |
| Gross Profit | 865.25M | 1.00B | 1.09B | 1.20B | 1.32B | 1.16B |
| EBITDA | 22.84M | 89.22M | 95.34M | 135.28M | 253.93M | 246.46M |
| Net Income | -78.11M | -20.33M | -15.29M | 36.61M | 153.75M | 139.19M |
Balance Sheet | ||||||
| Total Assets | 749.39M | 860.81M | 950.88M | 953.94M | 919.54M | 800.14M |
| Cash, Cash Equivalents and Short-Term Investments | 1.26M | 1.95M | 2.54M | 1.79M | 2.39M | 4.24M |
| Total Debt | 940.71M | 936.11M | 972.65M | 896.01M | 791.05M | 589.36M |
| Total Liabilities | 1.27B | 1.31B | 1.39B | 1.39B | 1.34B | 1.02B |
| Stockholders Equity | -521.34M | -451.59M | -441.93M | -438.18M | -424.95M | -223.98M |
Cash Flow | ||||||
| Free Cash Flow | -49.98M | 3.64M | -66.08M | -33.32M | 233.11M | 240.59M |
| Operating Cash Flow | -28.52M | 27.14M | -9.03M | 36.14M | 300.01M | 279.66M |
| Investing Cash Flow | -21.45M | -26.29M | -58.35M | -70.61M | -66.64M | -39.02M |
| Financing Cash Flow | 49.65M | -1.44M | 68.13M | 33.87M | -235.22M | -237.99M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | $1.63B | 18.23 | 8.82% | 2.97% | 1.78% | -25.36% | |
66 Neutral | $614.02M | 13.07 | 9.96% | 7.65% | -4.61% | -25.66% | |
66 Neutral | $1.21B | 5.55 | 26.20% | 2.29% | -6.03% | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | $1.09B | ― | -1.18% | 4.74% | 5.37% | -127.27% | |
48 Neutral | $87.51M | -1.03 | -9999.00% | ― | -9.47% | 48.11% | |
39 Underperform | $95.95M | ― | ― | ― | -16.95% | -88.00% |
Sleep Number Corporation announced on November 5, 2025, that it has secured an amendment and extension of its credit agreement through 2027, which aligns with its planned turnaround strategy. This updated agreement, reflecting increased covenant levels and expanded addbacks, demonstrates lender confidence and provides financial flexibility, supporting the company’s expectation to comply with new covenants and generate meaningful free cash flow in 2026.
The most recent analyst rating on (SNBR) stock is a Sell with a $5.00 price target. To see the full list of analyst forecasts on Sleep Number stock, see the SNBR Stock Forecast page.
On November 4, 2025, Sleep Number Corporation executed a Twelfth Amendment to its Credit and Security Agreement, extending the maturity date to December 3, 2027, and adjusting various financial covenants and credit facilities. This amendment signifies a strategic financial restructuring for the company, ensuring compliance with all covenants and facilitating the retirement of Board member Stephen L. Gulis, Jr., who stepped down following the amendment’s qualification as a debt refinancing.
The most recent analyst rating on (SNBR) stock is a Sell with a $5.00 price target. To see the full list of analyst forecasts on Sleep Number stock, see the SNBR Stock Forecast page.